Pharmaxis granted FDA clearance to produce Aridol locally for US market

ASX-listed pharmaceutical company, Pharmaxis has today been granted FDA clearance to commence Sydney-based production of its asthma diagnostic medication, Aridol for the US. The approval follows hot-on-the-heels of the FDA’s recent inspection of the Sydney facility which manufactures Aridol for Australia, South Korea and Europe, and Bronchitol for Australia, Europe and Russia respectively. Following FDA…

Read More

Low in magnesium? Talk to your doctor today.

Have you checked your magnesium levels lately? Stress, a poor diet and lack of vitamin D can strip the body of this vital mineral, together with excessive exercise and alcohol consumption, and Type 2 diabetes. Magnesium keeps your heart, muscles and blood pressure in check, maintains strong bones and regulates body temperature. A lack of…

Read More

Childhood depression and obesity link

The most recent childhood obesity data is cause for concern, with almost 28 per cent of Australian children recorded as either overweight or obese in 2014-15. A recent meta-analysis of more than 51,000 study participants has revealed a positive link between childhood and adolescent obesity and depression. Australian kids who are overweight and obese are…

Read More